Literature DB >> 26425304

Isolation of Mycobacterium fortuitum in sputum specimens of a patient with chronic cough: Is it clinically significant?

M R Radzniwan1, H Tohid2, S Ahmad3, Ali F Mohd4, F Md Anshar5.   

Abstract

Managing chronic cough is diagnostically challenging especially in primary care. This case report highlights the difficulties experienced in approaching a case of chronic cough from a primary care perspective. The discussion also involves the clinical significance and treatment dilemma of M. fortuitum chelonae complex that was isolated from the sputum cultures of an elderly woman who presented with chronic cough for more than a year.

Entities:  

Keywords:  chronic cough; mycobacterium; mycobacterium fortuitum; nontuberculous; primary care; sputum culture

Year:  2014        PMID: 26425304      PMCID: PMC4568725     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  10 in total

1.  Clinical and pathologic features of Mycobacterium fortuitum infections. An emerging pathogen in patients with AIDS.

Authors:  M B Smith; V J Schnadig; M C Boyars; G L Woods
Journal:  Am J Clin Pathol       Date:  2001-08       Impact factor: 2.493

2.  Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines.

Authors:  Richard S Irwin; Michael H Baumann; Donald C Bolser; Louis-Philippe Boulet; Sidney S Braman; Christopher E Brightling; Kevin K Brown; Brendan J Canning; Anne B Chang; Peter V Dicpinigaitis; Ron Eccles; W Brendle Glomb; Larry B Goldstein; LeRoy M Graham; Frederick E Hargreave; Paul A Kvale; Sandra Zelman Lewis; F Dennis McCool; Douglas C McCrory; Udaya B S Prakash; Melvin R Pratter; Mark J Rosen; Edward Schulman; John Jay Shannon; Carol Smith Hammond; Susan M Tarlo
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

Review 3.  Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.

Authors:  Peter V Dicpinigaitis
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

Review 4.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

5.  Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.

Authors:  P Ruszniewski; C Soufflet; P Barthélémy
Journal:  Aliment Pharmacol Ther       Date:  2008-07-30       Impact factor: 8.171

6.  Isolation of atypical mycobacteria from clinical material in Malaysia.

Authors:  S Y Khor; M Jegathesan
Journal:  Med J Malaysia       Date:  1983-06

7.  Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens.

Authors:  Sunghoon Park; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Kyung Soo Lee; Nam Yong Lee; Won-Jung Koh
Journal:  Respir Med       Date:  2007-11-09       Impact factor: 3.415

Review 8.  Prevalence, pathogenesis, and causes of chronic cough.

Authors:  Kian Fan Chung; Ian D Pavord
Journal:  Lancet       Date:  2008-04-19       Impact factor: 79.321

9.  Mycobacterium fortuitum lung abscess treated with ciprofloxacin.

Authors:  J Vadakekalam; M J Ward
Journal:  Thorax       Date:  1991-10       Impact factor: 9.139

Review 10.  Chronic cough: epidemiology.

Authors:  A H Morice
Journal:  Chron Respir Dis       Date:  2008       Impact factor: 2.444

  10 in total
  1 in total

1.  Phenotypic and genomic hallmarks of a novel, potentially pathogenic rapidly growing Mycobacterium species related to the Mycobacterium fortuitum complex.

Authors:  Reem Gharbi; Varun Khanna; Wafa Frigui; Besma Mhenni; Roland Brosch; Helmi Mardassi
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.